James V. Mazzo is President & VP at ABBOTT LABORATORIES (ABT). They have made 2 open-market trades across 2 companies since 2006, most recently 2014-02-11.
CIK 0001227297
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABT | SELL | 2012-05-08 | 2012-05-10 | $62.53 | $3.1M | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2012-02-29 | 2012-03-02 | $56.69 | $37K | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2012-02-27 | 2012-02-28 | $56.61 | $57K | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2011-10-24 | 2011-10-26 | $53.32 | $2.5M | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2011-10-24 | 2011-10-26 | $53.49 | $2.5M | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2011-10-24 | 2011-10-26 | $53.60 | $251K | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2011-02-28 | 2011-03-01 | $47.98 | $79K | -8.3% | -2.3% | -2.3% |
| EYE | SELL | 2007-11-30 | 2007-12-14 | $27.63 | $193 | +4.6% | -3.2% | -3.2% |
| EYE | SELL · 10b5-1 | 2007-04-27 | 2007-04-30 | $41.31 | $3.0M | +4.6% | -3.2% | -3.2% |
| EYE | SELL · 10b5-1 | 2006-12-08 | 2006-12-11 | $36.59 | $2.3M | +4.6% | -3.2% | -3.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.